Search

everythinglearnresearchcommunity

for

Search:↓

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Trilostane treatment led to full hair regrowth in most Pomeranians and all miniature poodles with alopecia X.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Cyproterone acetate was effective in treating acne, hirsutism, and alopecia with few side effects.

Finasteride and levofloxacin effectively reduce chronic bacterial prostatitis severity.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

A male with aromatase deficiency improved bone health with estradiol treatment.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Most skin changes during pregnancy go away after giving birth.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Zebrafish helped find new ways to prevent drug-induced hair cell death and potential treatments for hearing loss.

Sex and stress steroids quickly change brain cell structures in the hippocampus.

Diane® is an effective contraceptive that also helps treat acne and mild hair growth issues.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.